BioXcel Therapeutics, Inc. (BTAI)
1.55
-0.18
(-10.40%)
USD |
NASDAQ |
Mar 10, 16:00
1.56
+0.01
(+0.65%)
After-Hours: 17:50
BioXcel Therapeutics Revenue (Annual) : 2.266M for Dec. 31, 2024
Revenue (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Annual) Benchmarks
| Rigel Pharmaceuticals, Inc. | 294.28M |
| Puma Biotechnology, Inc. | 228.37M |
| Quince Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 1.072B |
| Alnylam Pharmaceuticals, Inc. | 3.714B |